Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Curis Stock Price, Quotes and Forecasts | NASDAQ:CRIS | Benzinga
Explore Curis stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRIS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Curis (CRIS) stock?
You can purchase shares of Curis (NASDAQ:CRIS) through any online brokerage.
Who are Curis (CRIS) competitors?
Other companies in Curis’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Evaxion (NASDAQ:EVAX), ABVC BioPharma (NASDAQ:ABVC), Longeveron (NASDAQ:LGVN) and Apimeds Pharmaceuticals (AMEX:APUS).
What is the forecast, or price target, for Curis (CRIS) stock?
Curis has a consensus price target of $15.50.
What is the current price for Curis (CRIS)?
The stock price for Curis (NASDAQ: CRIS) is $2.165 last updated May 29, 2025 at 10:58 AM EDT.
Does Curis (CRIS) pay a dividend?
There are no upcoming dividends for Curis.
When is Curis (NASDAQ:CRIS) reporting earnings?
Curis’s Q2 earnings are confirmed for Thursday, July 31, 2025.
Is Curis (CRIS) going to split?
There is no upcoming split for Curis.
What sector and industry does Curis (CRIS) operate in?
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
